Stanley C. Erck, President and CEO at NOVAVAX INC (NVAX), sold 67,090 shares at $109.25 ($7.4M) on 2020-09-29, disclosed to the SEC on 2020-09-30.
Open-market sale of $7.4M NVAX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $107.22 | 275 | $30K | 0.4% |
| 2 | $108.20 | 3,739 | $405K | 5.5% |
| 3 | $108.20 | 3,739 | $405K | 5.5% |
| 4 | $109.07 | 6,661 | $727K | 9.8% |
| 5 | $109.07 | 6,661 | $727K | 9.8% |
| 6 | $109.98 | 8,132 |
| $894K |
| 12.1% |
| 7 | $109.98 | 8,132 | $894K | 12.1% |
| 8 | $110.97 | 2,343 | $260K | 3.5% |
| 9 | $110.97 | 2,343 | $260K | 3.5% |
| 10 | $111.18 | 1,338 | $149K | 2.0% |
| 11 | $111.18 | 11,429 | $1.3M | 17.2% |
| 12 | $111.92 | 215 | $24K | 0.3% |
| 13 | $113.02 | 726 | $82K | 1.1% |
| 14 | $113.02 | 726 | $82K | 1.1% |
| 15 | $113.81 | 401 | $46K | 0.6% |
| 16 | $115.23 | 1,002 | $116K | 1.6% |
| 17 | $115.23 | 1,002 | $116K | 1.6% |
| 18 | $116.08 | 950 | $110K | 1.5% |
| 19 | $116.08 | 950 | $110K | 1.5% |
| 20 | $117.07 | 551 | $65K | 0.9% |
| 21 | $117.07 | 551 | $65K | 0.9% |
| 22 | $106.22 | 1,000 | $106K | 1.4% |
| 23 | $107.25 | 1,000 | $107K | 1.4% |
| 24 | $108.40 | 1,112 | $121K | 1.6% |
| 25 | $108.40 | 1,112 | $121K | 1.6% |
| 26 | $109.25 | 1,000 | $109K | 1.5% |
| Total | $110.28 avg | 67,090 | $7.4M | 100% |
| Filing → |
| MXCT | SELL | 2024-10-02 | $358K | — | Filing → |
| MXCT | SELL | 2024-09-05 | $383K | — | Filing → |
| NVAX | SELL | 2021-10-05 | $16.6M | — | Filing → |